\-\ Texto\\:\\ \ \(0\)\
\-\ ataxia\\,\\ arm\\ drift\\,\\ tongue\\ deviation\ \(1\)\
\-\ conservative\\ therapy\\ with\\ anticoagulation\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\:\\ bilateral\\ cerebellar\\ infarcts\\ of\\ varying\\ ages\ \(0\)\
\-\ \\â\\€\\¢\\ cta\\:\\ dissection\\ of\\ \\ high\\ cervical\\ and\\ intracranial\\ portion\\ of\\ the\\ left\\ vertebral\\ artery\ \(0\)\
\-\ vertebral\\ artery\\ dissection\\ with\\ cerebellar\\ infarction\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ fibromuscular\\ dysplasia\ \(0\)\
\-\ \\â\\€\\¢\\ vertebral\\ artery\\ dissection\ \(0\)\
\-\ 56\\ year\\ old\\ man\\ with\\ 5\\ year\\ history\\ of\\ multiple\\ sclerosis\\.\\ \\ presents\\ with\\ new\\ onset\\ right\\ sided\\ weakness\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dissection\\:\\ 0\\.17261909207363993\ \(0\)\
\-\ vertebral\\:\\ 0\\.13897793508543527\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.12879570013116887\ \(0\)\
\-\ artery\\:\\ 0\\.10456972570307667\ \(0\)\
\-\ cerebellar\\:\\ 0\\.10097588243954587\ \(0\)\
\-\ drift\\:\\ 0\\.0879126459064127\ \(0\)\
\-\ sclerosis\\:\\ 0\\.08409082831305054\ \(0\)\
\-\ fibromuscular\\:\\ 0\\.07612906693075364\ \(0\)\
\-\ tongue\\:\\ 0\\.07129589741537361\ \(0\)\
\-\ varying\\:\\ 0\\.06861446485200244\ \(0\)\
\-\ ages\\:\\ 0\\.06637296589608735\ \(0\)\
\-\ deviation\\:\\ 0\\.06537626241276641\ \(0\)\
\-\ infarcts\\:\\ 0\\.06295905094233413\ \(0\)\
\-\ ataxia\\:\\ 0\\.06256196139612519\ \(0\)\
\-\ 56\\:\\ 0\\.06161685356753682\ \(0\)\
\-\ cta\\:\\ 0\\.06107958352434118\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.05911929799501689\ \(0\)\
\-\ intracranial\\:\\ 0\\.04947276351903702\ \(0\)\
\-\ multiple\\:\\ 0\\.04930975351997997\ \(0\)\
\-\ arm\\:\\ 0\\.04902844467310341\ \(0\)\
\-\ infarction\\:\\ 0\\.04784258143600123\ \(0\)\
\-\ conservative\\:\\ 0\\.046751247151975595\ \(0\)\
\-\ dysplasia\\:\\ 0\\.04620685908828362\ \(0\)\
\-\ weakness\\:\\ 0\\.0434741281236765\ \(0\)\
\-\ sided\\:\\ 0\\.0432811864814609\ \(0\)\
\-\ cervical\\:\\ 0\\.04253549872043327\ \(0\)\
\-\ portion\\:\\ 0\\.04240009105971351\ \(0\)\
\-\ new\\:\\ 0\\.04079161612055559\ \(0\)\
\-\ onset\\:\\ 0\\.03695097569760479\ \(0\)\
\-\ 5\\:\\ 0\\.034248772910194014\ \(0\)\
\-\ high\\:\\ 0\\.032034877548997476\ \(0\)\
\-\ therapy\\:\\ 0\\.03129644926357004\ \(0\)\
\-\ \\:\\:\\ 0\\.03096643331481274\ \(0\)\
\-\ metastatic\\:\\ 0\\.029467252104330002\ \(0\)\
\-\ bilateral\\:\\ 0\\.02840846204540334\ \(0\)\
\-\ man\\:\\ 0\\.027683997850547933\ \(0\)\
\-\ mri\\:\\ 0\\.026894189793350957\ \(0\)\
\-\ year\\:\\ 0\\.026194664911586705\ \(0\)\
\-\ presents\\:\\ 0\\.023912935554903092\ \(0\)\
\-\ disease\\:\\ 0\\.01913339097555759\ \(0\)\
\-\ history\\:\\ 0\\.016167322434343608\ \(0\)\
\-\ left\\:\\ 0\\.013097332455793352\ \(0\)\
\-\ right\\:\\ 0\\.01235111930288242\ \(0\)\
\-\ old\\:\\ 0\\.01198540543646924\ \(0\)\
\-\ \\,\\:\\ 0\\.007416714123761298\ \(0\)\
\-\ with\\:\\ 0\\.006411187730952862\ \(0\)\
\-\ of\\:\\ 0\\.006383769906739092\ \(0\)\
\-\ and\\:\\ 0\\.0024658767908523073\ \(0\)\
\-\ the\\:\\ 0\\.0018938258178578876\ \(0\)\
\-\ \\.\\:\\ 0\\.0004862950150321407\ \(0\)\
